Skip to content
Screener

Beta Bionics BBNX Q3 2025 earnings

Reported October 28, 2025 · After market close

Revenue$27.3MMiss by $1.7M
EPS-$0.33Beat by $0.12
Revenue estimate$28.9M
EPS estimate-$0.45

Next report

Oct 27, 2026 (in 2 months)
Revenue estimate$35.0M
EPS estimate-$0.55

Financials

Q3 2025

Income statement

See full
Revenue$27.3M+63.1%
Gross profit$15.1M+69.6%
Operating income-$17.0M-55.3%
Net income-$14.2M-45.9%
EPS (diluted)-$0.33+77.4%

Balance sheet

See full
Cash & equivalents$38.5M+120%
Total debt$7.7M—
Total equity$294.8M+229%
Total assets$330.0M—

Cash flow

See full
Operating cash flow-$8.7M+9.2%
CapEx$1.3M-33.3%
Free cash flow-$10.0M+13.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$863.75M—
Enterprise value$832.95M—
P/S9.8×—

Profitability

See full
Gross margin54.5%+0.5pp
Operating margin-77.4%-7.2pp
Net margin-87.9%-9.5pp
FCF margin-68.3%-14.8pp

Returns & leverage

See full
Debt / equity0×—
Current ratio10.6×—

Segments

By product

See full
I Let$14.2M+28.4%
Single Use Products$6.8M+100%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q3 2025 earnings?
Beta Bionics (BBNX) reported Q3 2025 earnings on October 28, 2025 after market close.
What were Beta Bionics's Q3 2025 revenue and EPS?
Beta Bionics reported revenue of $27.3M and eps of $-0.33 for Q3 2025.
Did Beta Bionics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $28.9M by $1.7M. EPS beat the consensus estimate of $-0.45 by $0.12.
How did Beta Bionics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 63.1% from $16.7M a year earlier and eps grew 78.8% from $-1.55.
Where can I find Beta Bionics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-006720) and the 10-Q periodic report (0001193125-25-253538) directly on SEC EDGAR. The filing index links above go to sec.gov.